South and Central America Allergy Immunotherapies Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South and Central America Allergy Immunotherapies Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South and Central America Allergy Immunotherapies Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South and Central America Allergy Immunotherapies Market Regional Analysis

6.2 South and Central America Allergy Immunotherapies Market Revenue 2017-2027 (US$ Million)

6.3 South and Central America Allergy Immunotherapies Market Forecast Analysis

7. South and Central America Allergy Immunotherapies Market Analysis – by Treatment

7.1 Subcutaneous Immunotherapy

7.1.1 Overview
7.1.2 Subcutaneous Immunotherapy: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Sublingual Immunotherapy

7.2.1 Overview
7.2.2 Sublingual Immunotherapy: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. South and Central America Allergy Immunotherapies Market Analysis – by Allergy type

8.1 Allergic Rhinitis

8.1.1 Overview
8.1.2 Allergic Rhinitis: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Asthma

8.2.1 Overview
8.2.2 Asthma: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Food Allergy

8.3.1 Overview
8.3.2 Food Allergy: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Venom Allergy

8.4.1 Overview
8.4.2 Venom Allergy: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. South and Central America Allergy Immunotherapies Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Hospital Pharmacy: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Retail Pharmacy

9.2.1 Overview
9.2.2 Retail Pharmacy: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Online Pharmacy

9.3.1 Overview
9.3.2 Online Pharmacy: South and Central America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. South and Central America Allergy Immunotherapies Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America

10.2.1 South and Central America Allergy Immunotherapies Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 South and Central America Allergy Immunotherapies Market – Revenue and Forecast Analysis – by Country
10.2.1.1 Brazil: South and Central America Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 Brazil: South and Central America Allergy Immunotherapies Market Breakdown, by Treatment
10.2.1.1.2 Brazil: South and Central America Allergy Immunotherapies Market Breakdown, by Allergy type
10.2.1.1.3 Brazil: South and Central America Allergy Immunotherapies Market Breakdown, by Distribution Channel

10.2.1.2 Argentina: South and Central America Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Argentina: South and Central America Allergy Immunotherapies Market Breakdown, by Treatment
10.2.1.2.2 Argentina: South and Central America Allergy Immunotherapies Market Breakdown, by Allergy type
10.2.1.2.3 Argentina: South and Central America Allergy Immunotherapies Market Breakdown, by Distribution Channel

10.2.1.3 Rest of South and Central America : South and Central America Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Rest of South and Central America : South and Central America Allergy Immunotherapies Market Breakdown, by Treatment
10.2.1.3.2 Rest of South and Central America : South and Central America Allergy Immunotherapies Market Breakdown, by Allergy type
10.2.1.3.3 Rest of South and Central America : South and Central America Allergy Immunotherapies Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 HAL Allergy B.V.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 ALK Abello A/S

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Stallergenes Greer

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Anergis

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Circassia

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

South and Central America Allergy Immunotherapies Market

Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)); Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Country